These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34495311)

  • 1. Pretransplantation EASIX predicts intensive care unit admission in allogeneic hematopoietic cell transplantation.
    Peña M; Salas MQ; Mussetti A; Moreno-Gonzalez G; Bosch A; Patiño B; Jiménez L; Kara M; Parody R; Sureda A
    Blood Adv; 2021 Sep; 5(17):3418-3426. PubMed ID: 34495311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretransplantation EASIX Score Predicts Nonrelapse and Overall Mortality of Adult Patients Undergoing Single-Unit Unrelated Cord Blood Transplantation.
    Fujita S; Monna-Oiwa M; Kato S; Isobe M; Takahashi S; Nannya Y; Konuma T
    Transplant Cell Ther; 2023 Sep; 29(9):580.e1-580.e8. PubMed ID: 37402420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Pretransplantation Prediction Models for Nonrelapse Mortality in Patients with Myelofibrosis Undergoing Allogeneic Stem Cell Transplantation.
    Acosta-Medina AA; Baranwal A; Johnson IM; Kharfan-Dabaja MA; Murthy H; Palmer JM; Sproat L; Mangaonkar A; Shah MV; Hogan WJ; Litzow MR; Tefferi A; Alkhateeb HB
    Transplant Cell Ther; 2023 Jun; 29(6):360.e1-360.e8. PubMed ID: 36773650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Easix Score Correlates With Endothelial Dysfunction Biomarkers and Predicts Risk of Acute Graft-Versus-Host Disease After Allogeneic Transplantation.
    Pedraza A; Salas MQ; Rodríguez-Lobato LG; Escribano-Serrat S; Suárez-Lledo M; Martínez-Cebrian N; Solano MT; Arcarons J; Rosiñol L; Gutiérrez-García G; Fernández-Avilés F; Moreno-Castaño AB; Molina P; Pino M; Carreras E; Díaz-Ricart M; Rovira M; Palomo M; Martínez C
    Transplant Cell Ther; 2024 Feb; 30(2):187.e1-187.e12. PubMed ID: 38000709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantation.
    Sanchez-Escamilla M; Flynn J; Devlin S; Maloy M; Fatmi SA; Tomas AA; Escribano-Serrat S; Ponce D; Sauter CS; Giralt SA; Scordo M; Perales MA
    Bone Marrow Transplant; 2023 May; 58(5):498-505. PubMed ID: 36721042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surrogates of Endothelial Injury Predict Survival After Post-transplant Cyclophosphamide.
    Baranwal A; Langer KJ; Kharfan-Dabaja MA; Ayala E; Foran J; Murthy H; Roy V; Iqbal M; Palmer J; Sproat LZ; Chhabra S; Khera N; Durani U; Hefazi M; Mangaonkar A; Shah MV; Litzow MR; Hogan WJ; Alkhateeb HB
    Transplant Cell Ther; 2024 Aug; ():. PubMed ID: 39154913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial Activation and Stress Index (EASIX) at Admission Predicts Fluid Overload in Recipients of Allogeneic Stem Cell Transplantation.
    Varma A; Rondon G; Srour SA; Chen J; Ledesma C; Champlin RE; Ciurea SO; Saliba RM
    Biol Blood Marrow Transplant; 2020 May; 26(5):1013-1020. PubMed ID: 32045652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation.
    Nawas MT; Sanchez-Escamilla M; Devlin SM; Maloy MA; Ruiz JD; Sauter CS; Giralt SA; Perales MA; Scordo M
    Blood Adv; 2022 Nov; 6(22):5898-5907. PubMed ID: 35977079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma.
    Song GY; Jung SH; Kim K; Kim SJ; Yoon SE; Lee HS; Kim M; Ahn SY; Ahn JS; Yang DH; Kim HJ; Lee JJ
    BMC Cancer; 2020 Aug; 20(1):803. PubMed ID: 32831058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EASIX predicts non-relapse mortality after haploidentical transplantation with post-transplant cyclophosphamide.
    Mariotti J; Magri F; Giordano L; De Philippis C; Sarina B; Mannina D; Taurino D; Santoro A; Bramanti S
    Bone Marrow Transplant; 2023 Mar; 58(3):247-256. PubMed ID: 36414698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EASIX-1year and late mortality after allogeneic stem cell transplantation.
    Kordelas L; Terzer T; Gooley T; Davis C; Sandmaier BM; Sorror M; Penack O; Schaeper NDE; Blau IW; Beelen D; Radujkovic A; Dreger P; Luft T
    Blood Adv; 2023 Sep; 7(18):5374-5381. PubMed ID: 37477588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial Activation and Stress Index in adults undergoing allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based prophylaxis.
    Escribano-Serrat S; Rodríguez-Lobato LG; Charry P; Martínez-Cibrian N; Suárez-Lledó M; Rivero A; Moreno-Castaño AB; Solano MT; Arcarons J; Nomdedeu M; Cid J; Lozano M; Pedraza A; Rosiñol L; Esteve J; Urbano-Ispizua Á; Palomo M; Fernández-Avilés F; Martínez C; Díaz-Ricart M; Carreras E; Rovira M; Salas MQ
    Cytotherapy; 2024 Jan; 26(1):73-80. PubMed ID: 37952139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis.
    Luft T; Benner A; Jodele S; Dandoy CE; Storb R; Gooley T; Sandmaier BM; Becker N; Radujkovic A; Dreger P; Penack O
    Lancet Haematol; 2017 Sep; 4(9):e414-e423. PubMed ID: 28733186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a prospective study.
    Penack O; Luft T; Peczynski C; Benner A; Sica S; Arat M; Itäla-Remes M; Corral LL; Schaap NPM; Karas M; Raida L; Schroeder T; Dreger P; Metafuni E; Ozcelik T; Sandmaier BM; Kordelas L; Moiseev I; Schoemans H; Koenecke C; Basak GW; Peric Z
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38199608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EASIX and mortality after allogeneic stem cell transplantation.
    Luft T; Benner A; Terzer T; Jodele S; Dandoy CE; Storb R; Kordelas L; Beelen D; Gooley T; Sandmaier BM; Sorror M; Zeisbrich M; Radujkovic A; Dreger P; Penack O
    Bone Marrow Transplant; 2020 Mar; 55(3):553-561. PubMed ID: 31558788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preconditioning Modified-Easix as a Predictor of Prognosis in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
    Yegin ZA; Savaş EM; Yıldız Ş; Kök Mİ; Erdemir MB; Bostankolu Değirmenci B; Özkurt ZN; Yağcı M
    Indian J Hematol Blood Transfus; 2023 Oct; 39(4):586-597. PubMed ID: 37786821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EASIX (endothelial activation and stress index) predicts mortality in patients with coronary artery disease.
    Finke D; Hund H; Frey N; Luft T; Lehmann LH
    Clin Res Cardiol; 2024 Sep; ():. PubMed ID: 39256221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell Transplantation.
    Farhadfar N; Dias A; Wang T; Fretham C; Chhabra S; Murthy HS; Broglie L; D'Souza A; Gadalla SM; Gale RP; Hashmi S; Al-Homsi AS; Hildebrandt GC; Hematti P; Rizzieri D; Chee L; Lazarus HM; Bredeson C; Jaimes EA; Beitinjaneh A; Bashey A; Prestidge T; Krem MM; Marks DI; Benoit S; Yared JA; Nishihori T; Olsson RF; Freytes CO; Stadtmauer E; Savani BN; Sorror ML; Ganguly S; Wingard JR; Pasquini M
    Transplant Cell Ther; 2021 May; 27(5):410-422. PubMed ID: 33775617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-Adjusted Endothelial Activation and Stress Index for Coronavirus Disease 2019 at Admission Is a Reliable Predictor for 28-Day Mortality in Hospitalized Patients With Coronavirus Disease 2019.
    Pérez-García F; Bailén R; Torres-Macho J; Fernández-Rodríguez A; Jiménez-Sousa MÁ; Jiménez E; Pérez-Butragueño M; Cuadros-González J; Cadiñanos J; García-García I; Jiménez-González M; Ryan P; Resino S
    Front Med (Lausanne); 2021; 8():736028. PubMed ID: 34568391
    [No Abstract]   [Full Text] [Related]  

  • 20. Association Between Endothelial Activation and Stress Index and 28-Day Mortality in Septic ICU patients: a Retrospective Cohort Study.
    Xu HB; Ye Y; Xue F; Wu J; Suo Z; Zhang H
    Int J Med Sci; 2023; 20(9):1165-1173. PubMed ID: 37575274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.